Visual Evoked Potentials in Interictal Migraine: No Confirmation of Abnormal Habituation-Reference-Cited by-同舟云学术

Visual Evoked Potentials in Interictal Migraine: No Confirmation of Abnormal Habituation

Published:2013-01-08 Issue:7 Volume:53 Page:1071-1086
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache: The Journal of Head and Face Pain

Author:

Omland Petter M.¹,Nilsen Kristian B.¹,Uglem Martin¹,Gravdahl Gøril¹,Linde Mattias,Hagen Knut,Sand Trond

Affiliation:

1. Department of Neuroscience; Norwegian University of Science and Technology; Trondheim; Norway

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/head.12006/fullpdf

Reference49 articles.

1. The international classification of headache disorders: 2nd edition;Headache Classification Subcommittee of the International Headache Society;Cephalalgia,2004

2. Habituation revisited: An updated and revised description of the behavioral characteristics of habituation;Rankin;Neurobiol Learn Mem,2009

3. Visual evoked potentials during long periods of pattern-reversal stimulation in migraine;Afra;Brain,1998

4. Comparison of visual and auditory evoked cortical potentials in migraine patients between attacks;Afra;Clin Neurophysiol,2000

5. Interictal abnormalities of gamma band activity in visual evoked responses in migraine: An indication of thalamocortical dysrhythmia?;Coppola;Cephalalgia,2007

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EEG Changes in Migraine—Can EEG Help to Monitor Attack Susceptibility?;Brain Sciences;2024-05-17

2. Virtual dynamic interaction games reveal impaired multisensory integration in women with migraine;Headache: The Journal of Head and Face Pain;2024-05

3. Exploring the Therapeutic Potential of Quadripulse rTMS over the Visual Cortex: A Proof-of-Concept Study in Healthy Volunteers and Chronic Migraine Patients with Medication Overuse Headache;Biomedicines;2024-01-26

4. No Evidence of Cross-Orientation Suppression Differences in Migraine with Aura Compared to Healthy Controls;Vision;2024-01-19

5. Bimatoprost Ophthalmic Solution (BOS) 0.3 mg w/v for 1 Open Trial of Long-term Preventive Therapy of Migraine in 3 patients with Pathophysiologic Shift from Brain to Eye;Journal of Neuroscience and Neurological Disorders;2023-11-09